#116913
Re: Farmas USA
TGTX no la sigo, he mirado su último 10q
As of June 30, 2019, we had $85.0 million in cash and cash equivalents, and investment securities. The Company believes its cash, cash equivalents, and investment securities on hand as of June 30, 2019 along with the additional capital raised in the third quarter of 2019 (see Note 5) will be sufficient to fund the Company’s planned operations into the fourth quarter of 2020. The actual amount of cash that we will need to operate is subject to many factors, including, but not limited to, the timing, design and conduct of clinical trials for our drug candidates.
y tiene un s-3 fresquito reciente 08/30/2019
y tiene un s-3 fresquito reciente 08/30/2019